{
    "nct_id": "NCT03422198",
    "official_title": "Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer Compared to Standard of Care (SAVE)",
    "inclusion_criteria": "* Histologically confirmed endometrial carcinoma: endometrioid type, serous, and clear cell, to include tumors originating in the cervix, but are primarily located in the uterus, and for whom vaginal cuff brachytherapy is indicated. Carcinosarcoma and other sarcomas are permitted; Federation of Gynecology and Obstetrics (FIGO) stage I, with one of the following combinations of stage and grade:\n\n  * Stage IA, grade 2, 3\n  * Stage IB, grades 1-3\n  * Stage II, grades 1-3\n  * Stage IIIA, grades 1-3, not receiving EBRT as part of adjuvant therapy.\n* Participants post hysterectomy and free from residual disease.\n* World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG)-performance status 0-2.\n* Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.\n* Life expectancy of >2 years.\nHealthy volunteers allowed",
    "exclusion_criteria": "* Stages of endometrial carcinoma other than described.\n* Previous pelvic radiotherapy.\n* Interval between the hysterectomy and planned start of radiotherapy exceeding 16 weeks.",
    "miscellaneous_criteria": ""
}